US Patent 9381173 Isolated stereoisomeric forms of (S)2-N(3-O-(propan 2-Ol)-1-propyl-4-hydroxybenzene)-3-phenylpropylamide

Patent 9381173 was granted and assigned to Novaremed on July, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Novaremed

Current Assignee

Novaremed

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9381173

Date of Patent

July 5, 2016

Patent Application Number

14291901

Date Filed

May 30, 2014

Patent Primary Examiner

‌

Nyeemah A Grazier

Patent abstract

Isolated stereoisomeric forms of the compound (S)2-N(3-O-(propan 2-ol) -1-propyl-4-hydroxybenzene)-3-phenylpropylamide and uses in the treatment of pain.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9381173 Isolated stereoisomeric forms of (S)2-N(3-O-(propan 2-Ol)-1-propyl-4-hydroxybenzene)-3-phenylpropylamide

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API